Riaz Qureshi, PhD, MS
Assistant Professor, Ophthalmology

Publications

• Lee MJ, Lin JC, Qureshi R, Greenberg PB. Predictors of citation count for systematic reviews in ophthalmology. Graefes Arch Clin Exp Ophthalmol. 2023 Jan;261(1):281-282. PubMed PMID: 35943581
• Qureshi R, Mayo-Wilson E, Li T. Harms in Systematic Reviews Paper 1: An introduction to research on harms. J Clin Epidemiol. 2022 Mar;143:186-196. PubMed PMID: 34742788
• Qureshi R, Mayo-Wilson E, Rittiphairoj T, McAdams-DeMarco M, Guallar E, Li T. Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin. J Clin Epidemiol. 2022 Mar;143:212-223. PubMed PMID: 34742789
• Qureshi R, Mayo-Wilson E, Rittiphairoj T, McAdams-DeMarco M, Guallar E, Li T. Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms. J Clin Epidemiol. 2022 Mar;143:224-241. PubMed PMID: 34742790
• Phillips R, Cro S, Wheeler G, Bond S, Morris TP, Creanor S, Hewitt C, Love S, Lopes A, Schlackow I, Gamble C, MacLennan G, Habron C, Gordon AC, Vergis N, Li T, Qureshi R, Everett CC, Holmes J, Kirkham A, Peckitt C, Pirrie S, Ahmed N, Collett L, Cornelius V. Visualising harms in publications of randomised controlled trials: consensus and recommendations. BMJ. 2022 May 16;377:e068983. PubMed PMID: 35577357
• Qureshi R, Gough A, Loudon K. The SPIRIT Checklist-lessons from the experience of SPIRIT protocol editors. Trials. 2022 Apr 27;23(1):359. PubMed PMID: 35477436
• Protasio JN, King A, Pasquale LR, Barton K, Bonnar J, Qureshi R, Virgili G, Azuara-Blanco A. How Can We Quantify and Compare Harm in Surgical Trials?. Am J Ophthalmol. 2022 Sep;241:64-70. PubMed PMID: 35526589
• McCann P, Kruoch Z, Qureshi R, Li T. Effectiveness of interventions for dry eye: a protocol for an overview of systematic reviews. BMJ Open. 2022 Jun 7;12(6):e058708. PubMed PMID: 35672062
• Qureshi R, Chen X, Goerg C, Mayo-Wilson E, Dickinson S, Golzarri-Arroyo L, Hong H, Phillips R, Cornelius V, McAdams DeMarco M, Guallar E, Li T. Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials. Epidemiol Rev. 2022 Dec 21;44(1):55-66. PubMed PMID: 36065832
• McCann P, Abraham AG, Mukhopadhyay A, Panagiotopoulou K, Chen H, Rittiphairoj T, Gregory DG, Hauswirth SG, Ifantides C, Qureshi R, Liu SH, Saldanha IJ, Li T. Prevalence and Incidence of Dry Eye and Meibomian Gland Dysfunction in the United States: A Systematic Review and Meta-analysis. JAMA Ophthalmol. 2022 Dec 1;140(12):1181-1192. PubMed PMID: 36301551
• Kang C, Lin JC, Qureshi R, Scherer R, Greenberg PB. Author, study, and publication metrics of brief reports and full-length research articles in ophthalmology journals. Clin Exp Ophthalmol. 2022 Dec 23. [Epub ahead of print] PubMed PMID: 36562707
• Monaco W, Qureshi R, Meng H, Arif A, Aggarwal S. Risk factors for vision loss among nursing home residents: A cross-sectional analysis. Investigative Ophthalmology and Visual Science. 2022; 63(7):4238
• Qureshi R, E JY, Han G, Rittiphairoj T, Ng S, Wilson R, Abariga S, Li T. Certainty of evidence in Cochrane Eyes and Vision systematic reviews. Investigative Ophthalmology and Visual Science. 2022; 63(7):2137
• Qureshi R, Phillips R, Cornelius V, Mayo-Wilson E, Goerg C, Li T. Data visualization approaches to presenting harms in clinical trials. Clinical Trials. 2022; 64-65 [CP I 5-4]